About ECM Therapeutics
ECM Therapeutics is a private company based in Warrendale, Pennsylvania. It has reported $35,219,000 raised in one offering on Form D since June 2018. Its chief executive is Paul Fagan.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 28, 2018 | Jun 8, 2018amended Oct 10, 2025 | $35,219,000of $40.0M target | 190 | $185K | EquityRule 506(b) | Form D/A ↗7 earlier filings |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on ECM Therapeutics's Form D filed Oct 10, 2025.
PF
Paul Fagan
Chief Executive Officer and director
KC
Katie Collins
Executive officer and director
CS
Christine Sheehy
Executive officer
JD
Jenna Dziki
Executive officer
SB
Stephen Badylak
Executive officer and director
GH
George Hussey
Executive officer
LS
Lindsey Saldin
Executive officer
Sources
- SECECM Therapeutics, Inc. Form D/A, filed May 30, 2024
- SECECM Therapeutics, Inc. Form D/A, filed Jun 9, 2023
- SECECM Therapeutics, Inc. Form D/A, filed Sep 14, 2022
- SECECM Therapeutics, Inc. Form D/A, filed Jul 30, 2021
- SECECM Therapeutics, Inc. Form D/A, filed Sep 18, 2019
- SECECM Therapeutics, Inc. Form D/A, filed Jun 18, 2019
- SECECM Therapeutics, Inc. Form D, filed Jun 8, 2018
- SECECM Therapeutics, Inc. filing history